Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Almeida, Fausto ^a   Wolf, Julie M ^b   Da Silva, Thiago Aparecido ^a   Deleon Rodriguez, Carlos M ^b   Rezende, Caroline Patini ^a   Pessoni, André Moreira ^a   Fernandes, Fabrício Freitas ^a   Silva Rocha, Rafael ^a   Martinez, Roberto ^a   Rodrigues, Marcio L ^c,d   Roque Barreira, Maria Cristina ^a   Casadevall, Arturo ^e  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CONCANAVALIN A; GALECTIN 3; HEMOCYANIN; OVALBUMIN; PHYTOHEMAGGLUTININ; CYTOKINE; GALECTIN-3, HUMAN;

ANTIMICROBIAL ACTIVITY; BIOTECHNOLOGY; BRAIN; CELLS AND CELL COMPONENTS; DISEASE TREATMENT; EXPERIMENTAL STUDY; FUNGAL DISEASE; FUNGUS; GROWTH; IMMUNE SYSTEM; IMMUNITY; INHIBITION; PATHOGEN; PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL THERAPY; ARTICLE; BRAIN TISSUE; CELL DISRUPTION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE PREDISPOSITION; EXOSOME; EXPERIMENTAL INFECTION; FUNGAL CELL; FUNGUS GROWTH; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IN VITRO STUDY; INFECTION CONTROL; INNATE IMMUNITY; INTERNALIZATION; LUNG PARENCHYMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SPLEEN TISSUE; SURVIVAL ANALYSIS; SURVIVAL RATE; TH17 CELL; UPREGULATION; ADAPTIVE IMMUNITY; ANIMAL; BACTERIAL CAPSULE; BLOOD; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; SPLEEN;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; MAMMALIA; MUS;

ADAPTIVE IMMUNITY; ANIMALS; ANTIFUNGAL AGENTS; BACTERIAL CAPSULES; BRAIN; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; DISEASE MODELS, ANIMAL; GALECTIN 3; GENE EXPRESSION; HUMANS; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; SPLEEN;

EID: 85037984563     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-02126-7     Document Type: Article

References (54)

1. Heitman, J., Kozel, T. R., Kwon-Chung, J., Perfect, J. R. &Casadevall, A. Cryptococcus: From Human Pathogen to Model Yeast. (ASM Press: Washington, DC, 2011)
2. Barnett, J. A. A history of research on yeasts 14: medical yeasts part 2, Cryptococcus neoformans. Yeast (Chichester, Engl) 27, 875-904 (2010)
3. Lin, X. &Heitman, J. The biology of the Cryptococcus neoformans species complex. Annu. Rev. Microbiol. 60, 69-105 (2006)
4. Lindell, D. M., Ballinger, M. N., McDonald, R. A., Toews, G. B. &Huffnagle, G. B. Immunologic homeostasis during infection: coexistence of strong pulmonary cell-mediated immunity to secondary Cryptococcus neoformans infection while the primary infection still persists at low levels in the lungs. J. Immunol. 177, 4652-4661 (2006)
5. Coelho, C., Bocca, A. L. &Casadevall, A. The intracellular life of Cryptococcus neoformans. Annu Rev. Pathol.-Mech. 9, 219-238 (2014)
6. Longo, D. et al. Harrison's Principles of Internal Medicine. 18th edn, 1, 2, (McGraw-Hill: New York, 2011)
7. Zaragoza, O. et al. The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol. 68, 133-216 (2009)
8. Casadevall, A., Rosas, A. L. &Nosanchuk, J. D. Melanin and virulence in Cryptococcus neoformans. Curr. Opin. Microbiol. 3, 354-358 (2000)
9. Casadevall, A., &Perfect, J. R. Cryptococcus neoformans. (ASM Press: Washington, DC, 1998)
10. Almeida, F., Wolf, J. M. &Casadevall, A. Virulence-associated enzymes of Cryptococcus neoformans. Eukaryot. Cell. https://doi.org/10.1128/EC.00103-15 (2015)
11. Brown, L., Wolf, J. M., Prados-Rosales, R. &Casadevall, A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat. Rev. Microbiol. 13, 620-630 (2015)
12. Silva, T. A., Roque-Barreira, M. C., Casadevall, A. &Almeida, F. Extracellular vesicles from Paracoccidioides brasiliensis induced M1 polarization in vitro. Sci. Rep. 6, 35867 (2016)
13. Oliveira, D. L. et al. Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions. Infect. Immun. 78, 1601-1609 (2010)
14. Rodrigues, M. L. et al. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot. Cell 7, 58-67 (2008)
15. Vargas, G. et al. Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans. Cell. Microbiol. 17, 389-407 (2015)
16. Wolf, J. M., Rivera, J. &Casadevall, A. Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles. Cell. Microbiol. 14, 762-773 (2012)
17. Fermino, M. L. et al. Galectin-3 negatively regulates the frequency and function of CD4(+)CD25(+)Foxp3(+) regulatory T cells and influences the course of Leishmania major infection. Eur. J. Immunol. 43, 1806-1817 (2013)
18. Ferraz, L. C. et al. Lack of galectin-3 alters the balance of innate immune cytokines and confers resistance to Rhodococcus equi infection. Eur. J. Immunol. 38, 2762-2775 (2008)
19. van den Berg, T. K. et al. LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition. J. Immunol. 173, 1902-1907 (2004)
20. Baum, L. G., Garner, O. B., Schaefer, K. &Lee, B. Microbe-host interactions are positively and negatively regulated by galectin-glycan interactions. Front. Immunol. 5, 284 (2014)
21. Breuilh, L. et al. Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells. Infect. Immun. 75, 5148-5157 (2007)
22. Bernardes, E. S. et al. Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am. J. Pathol. 168, 1910-1920 (2006)
23. Ruas, L. P. et al. Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity. PLoS ONE 4, e4519 (2009)
24. Linden, J. R., Paepe, M. E., Laforce-Nesbitt, S. S. &Bliss, J. M. Galectin-3 plays an important role in protection against disseminated candidiasis. Med. Mycol. 51, 641-651 (2013)
25. Wu, S. Y., Yu, J. S., Liu, F. T., Miaw, S. C. &Wu-Hsieh, B. A. Galectin-3 negatively regulates dendritic cell production of IL-23/IL-17-axis cytokines in infection by Histoplasma capsulatum. J. Immunol. 190, 3427-3437 (2013)
26. Chen, H. L., Liao, F., Lin, T. N. &Liu, F. T. Galectins and neuroinflammation. Adv. Neurobiol. 9, 517-542 (2014)
27. Saegusa, J. et al. Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis. Am. J. Pathol. 174, 922-931 (2009)
28. Cherayil, B. J., Chaitovitz, S., Wong, C. &Pillai, S. Molecular cloning of a human macrophage lectin specific for galactose. Proc. Natl. Acad. Sci. USA 87, 7324-7328 (1990)
29. Liu, F. T. et al. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147, 1016-1028 (1995)
30. Sano, H. et al. Critical role of galectin-3 in phagocytosis by macrophages. J. Clin. Invest. 112, 389-397 (2003)
31. Vasta, G. R. Roles of galectins in infection. Nat. Rev. Microbiol. 7, 424-438 (2009)
32. Liu, F. T. &Hsu, D. K. The role of galectin-3 in promotion of the inflammatory response. Drug News Perspect. 20, 455-460 (2007)
33. Krzeslak, A. &Lipinska, A. Galectin-3 as a multifunctional protein. Cell Mol. Biol. Lett. 9, 305-328 (2004)
34. Fermin Lee, A. et al. Galectin-3 modulates Th17 responses by regulating dendritic cell cytokines. Am. J. Pathol. 183, 1209-1222 (2013)
35. Wozniak, K. L., Hardison, S. E., Kolls, J. K. &Wormley, F. L. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS ONE 6, e17204 (2011)
36. Wozniak, K. L., Kolls, J. K. &Wormley, F. L. Jr. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by gammadelta T cells. BMC Immunol. 13, 65 (2012)
37. Zhang, Y. et al. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am. J. Pathol. 175, 2489-2500 (2009)
38. Murdock, B. J., Huffnagle, G. B., Olszewski, M. A. &Osterholzer, J. J. Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production. Infect. Immun. 82, 937-948 (2014)
39. Jouault, T. et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J. Immunol. 177, 4679-4687 (2006)
40. Hernandez-Santos, N. &Gaffen, S. L. Th17 cells in immunity to Candida albicans. Cell Host Microbe 11, 425-435 (2012)
41. Fradin, C., Poulain, D. &Jouault, T. Beta-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3. Infect. Immun. 68, 4391-4398 (2000)
42. Henrick, K., Bawumia, S., Barboni, E. A. M., Mehul, B. &Hughes, R. C. Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3. Glycobiology 8, 45-57 (1998)
43. Kohatsu, L., Hsu, D. K., Jegalian, A. G., Liu, F. T. &Baum, L. G. Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans. J. Immunol. 177, 4718-4726 (2006)
44. Doering, T. L. How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu. Rev. Microbiol. 63, 223-247 (2009)
45. Guazzelli, L., McCabe, O. &Oscarson, S. Synthesis of part structures of Cryptococcus neoformans serotype C capsular polysaccharide. Carbohyd. Res. 433, 5-13 (2016)
46. Ascenzi, P. &Fasano, M. Serum heme-albumin: an allosteric protein. IUBMB Life 61, 1118-1122 (2009)
47. Meierhofer, T., van den Elsen, J. M., Cameron, P. J., Munoz-Berbel, X. &Jenkins, A. T. The interaction of serum albumin with cholesterol containing lipid vesicles. J. Fluoresc. 20, 371-376 (2010)
48. Hsu, D. K. et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156, 1073-1083 (2000)
49. Oliveira, A. F. et al. Paracoccin distribution supports its role in Paracoccidioides brasiliensis growth and dimorphic transformation. PLoS ONE 12, e0184010 (2017)
50. Casadevall, A. et al. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42, 1437-1446 (1998)
51. Chaturvedi, A. K. et al. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. PLoS ONE 9, e104316 (2014)
52. Rodrigues, M. L. et al. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot. Cell 6, 48-59 (2007)
53. Bray, N. L., Pimentel, H., Melsted, P. &Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525-527 (2016)
54. Robinson, M. D., McCarthy, D. J. &Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010)